Alberta confirms 1st death from rare blood clots linked to AstraZeneca vaccine

Alberta confirms 1st death from rare blood clots linked to AstraZeneca vaccine

Alberta is reporting its first death linked to the AstraZeneca-Oxford COVID-19 vaccine. In an email late Tuesday, Chief Medical Officer of Health Dr. Deena Hinshaw confirmed the first fatal case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a patient that had received the AstraZeneca vaccine. The email said the person who died was a woman in her 50s. It did not state where the woman was located. "Out of respect for patient confidentiality and the privacy of the grieving family, we will not be providing additional case information," said Hinshaw in a statement. "While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine." Hinshaw said the woman was only the second confirmed case of VIIT in the province, out of more than 253,000 doses of AstraZeneca or CoviSHIELD that have been administered. • Trudeau, Tam say all vaccines are safe and effective after NACI guidance causes confusion • Canadians over 30 should be offered AstraZeneca-Oxford COVID-19 vaccine, advisory body …
More on: www.cbc.ca